Modified Lentiviral Globin Gene Therapy for Pediatric β0/β0 Transfusion-Dependent β-Thalassemia: A Single-Center, Single-Arm Pilot Trial
Published: 17 April 2024| Version 2 | DOI: 10.17632/8rrszmkw89.2
Contributor:
Fangyuan HaoDescription
These data are the deposited supplemental information for the article entitled "Modified Lentiviral Globin Gene Therapy for Pediatric β0/β0 Transfusion-Dependent β-Thalassemia: A Single-Center, Single-Arm Pilot Trial" by Shiqi Li and Sikai Ling et al. in Cell Stem Cell
Files
Categories
Gene Therapy, Lentivirus, Beta Thalassemia
Funding
Young and Middle-aged Academic and Technical Leaders Reserve Talent Project of Yunnan Province
202205AC160074
Biomedical Major Project of Yunnan Province
202102AA100011
Key Forward-looking Fund from Shanghai Jiao Tong University
AF4150049
National Natural Science Foundation of China
32370148
Science and Technology Innovation Action Plan of Shanghai
24Z510200306
National Key Research and Development Program of China
2022YFC3400205